LivingGLP1
Study S000187

An Open-label,Sequential,Single-site Study to Evaluate the Pharmacokinetics of Digoxin When Coadministered With Polyethylene Glycol Loxenatide (PEX168) in Healthy Adult Subjects

Registration

Registration
NCT02472236
Study type
INTERVENTIONAL
Phase
PHASE1
Masking
NONE
Status
COMPLETED
Enrollment
16
Start
2015-06-08
Primary completion
2015-09-24
Lead sponsor
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Conditions
Healthy
Interventions
DRUG:PEX168; DRUG:Digoxin
Results posted
FALSE

Registered primary outcomes

  • Composite measure the plasma concentrations of Digoxin. [Baseline to Day44]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.